OpenURL Connection Search

Select item for more details and to access through your institution.

Long-term results of a phase 2 trial of nilotinib 400 mg twice daily in newly diagnosed patients with chronic-phase chronic myeloid leukemia.
Published in:
2020
By:
- Masarova, Lucia;
- Cortes, Jorge E.;
- Patel, Keyur P.;
- O'Brien, Susan;
- Nogueras‐Gonzalez, Graciela M.;
- Konopleva, Marina;
- Verstovsek, Srdan;
- Garcia‐Manero, Guillermo;
- Ferrajoli, Alessandra;
- Kadia, Tapan M.;
- Ravandi‐Kashani, Farhad;
- Borthakur, Gautam;
- DellaSala, Sara;
- Estrov, Zeev;
- Jabbour, Elias J.;
- Kantarjian, Hagop M.;
- Nogueras-Gonzalez, Graciela M;
- Garcia-Manero, Guillermo;
- Ravandi-Kashani, Farhad
Publication type:
journal article
2121. Isavuconazole (ISAV) as Primary Anti-Fungal Prophylaxis (PAP) in Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS): An Open-Label, Prospective Study.
Published in:
Open Forum Infectious Diseases, 2019, v. 6, p. S718, doi. 10.1093/ofid/ofz360.1801
By:
- Bose, Prithviraj;
- McCue, David;
- Wurster, Sebastian;
- Wiederhold, Nathan P;
- Kadia, Tapan M;
- Borthakur, Gautam;
- Ravandi-Kashani, Farhad;
- Masarova, Lucia;
- Konopleva, Marina;
- Estrov, Zeev;
- Takahashi, Koichi;
- Yilmaz, Musa;
- Rausch, Caitlin R;
- Marx, Kayleigh;
- Qiao, Wei;
- Huang, Xuelin;
- Bivins, Carol A;
- Pierce, Sherry A;
- Kantarjian, Hagop M;
- Kontoyiannis, Dimitrios P
Publication type:
Article
Current status and research directions in acute myeloid leukemia.
Published in:
Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01143-2
By:
- Kantarjian, Hagop;
- Borthakur, Gautam;
- Daver, Naval;
- DiNardo, Courtney D.;
- Issa, Ghayas;
- Jabbour, Elias;
- Kadia, Tapan;
- Sasaki, Koji;
- Short, Nicholas J.;
- Yilmaz, Musa;
- Ravandi, Farhad
Publication type:
Article
Liver elastography for risk-assessment of liver toxicity and risk factors for Sinusoidal obstruction syndrome in patients with acute lymphoblastic leukemia receiving inotuzumab ozogamicin.
Published in:
2024
By:
- Senapati, Jayastu;
- Jabbour, Elias;
- Short, Nicholas J.;
- Jain, Nitin;
- Haddad, Fadi;
- Bathala, Tharakeswara;
- Kovalenko, Iuliia;
- Bidikian, Aram;
- Ravandi, Farhad;
- Khouri, Issa;
- Kadia, Tapan M.;
- Garris, Rebecca;
- Montalban Bravo, Guillermo;
- Chien, Kelly;
- Shpall, Elizabeth;
- Kebriaei, Partow;
- Kantarjian, Hagop M.
Publication type:
Letter
Response patterns and impact of MRD in patients with IDH1/2-mutated AML treated with venetoclax and hypomethylating agents.
Published in:
Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00915-6
By:
- Hammond, Danielle;
- Loghavi, Sanam;
- Wang, Sa A.;
- Konopleva, Marina Y.;
- Kadia, Tapan M.;
- Daver, Naval G.;
- Ohanian, Maro;
- Issa, Ghayas C.;
- Alvarado, Yesid;
- Short, Nicholas J.;
- Sasaki, Koji;
- Pemmaraju, Naveen;
- Montalban-Bravo, Guillermo;
- Lachowiez, Curtis A.;
- Maiti, Abhishek;
- Garcia-Manero, Guillermo;
- Jabbour, Elias J.;
- Borthakur, Gautam;
- Ravandi, Farhad;
- Takahashi, Koichi
Publication type:
Article
Treatment of older adults with FLT3-mutated AML: Emerging paradigms and the role of frontline FLT3 inhibitors.
Published in:
Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00911-w
By:
- Short, Nicholas J.;
- Nguyen, Daniel;
- Ravandi, Farhad
Publication type:
Article
A Phase I study of Milademetan (DS3032b) in combination with low dose cytarabine with or without venetoclax in acute myeloid leukemia: Clinical safety, efficacy, and correlative analysis.
Published in:
Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00871-1
By:
- Senapati, Jayastu;
- Muftuoglu, Muharrem;
- Ishizawa, Jo;
- Abbas, Hussein A.;
- Loghavi, Sanam;
- Borthakur, Gautam;
- Yilmaz, Musa;
- Issa, Ghayas C.;
- Dara, Samuel I.;
- Basyal, Mahesh;
- Li, Li;
- Naqvi, Kiran;
- Pourebrahim, Rasoul;
- Jabbour, Elias J.;
- Kornblau, Steven M.;
- Short, Nicholas J.;
- Pemmaraju, Naveen;
- Garcia-Manero, Guillermo;
- Ravandi, Farhad;
- Khoury, Joseph
Publication type:
Article
The addition of all-trans retinoic acid to chemotherapy may not improve the outcome of patient with NPM1 mutated acute myeloid leukemia.
Published in:
Frontiers in Oncology, 2013, v. 3, p. 1, doi. 10.3389/fonc.2013.00218
By:
- Nazha, Aziz;
- Bueso-Ramos, Carlos;
- Estey, Eli;
- Faderl, Stefan;
- O'Brien, Susan;
- Fernandez, Michael H.;
- Nguyen, Martin;
- Koller, Charles;
- Freireich, Emil;
- Beran, Miloslav;
- Pierce, Sherry;
- Keating, Michael;
- Cortes, Jorge;
- Kantarjian, Hagop;
- Ravandi, Farhad
Publication type:
Article
Addition of All-Trans Retinoic Acid to the combination of Fludarabine, Cytarabine, Idarubicin, with or without GCSF in Older Patients with AML Does Not Improve The Outcome in Those with NPM1 Mutations The addition of All-Trans Retinoic Acid to Chemotherpay may not Improve The Outcome of Patient with NPM1 Mutated Acute Myeloid Leukemia
Published in:
Frontiers in Oncology, 2013, v. 3, p. 1, doi. 10.3389/fonc.2013.00218
By:
- Nazha, Aziz;
- Bueso-Ramos, Carlos;
- Estey, Eli;
- Faderl, Stefan;
- O'Brien, Susan;
- Fernandez, Michael H.;
- Nguyen, Martin;
- Koller, Charles;
- Freireich, Emil;
- Beran, Miloslav;
- Pierce, Sherry;
- Keating, Michael;
- Cortes, Jorge;
- Kantarjian, Hagop;
- Ravandi, Farhad
Publication type:
Article
Acute myeloid leukemia as a model for cancer therapy.
Published in:
Frontiers in Oncology, 2012, v. 2, p. 1, doi. 10.3389/fonc.2012.00139
By:
- Ravandi, Farhad
Publication type:
Article
Acute Myeloid Leukemia (AML) as a model for cancer therapy.
Published in:
Frontiers in Oncology, 2012, v. 2, p. 1, doi. 10.3389/fonc.2012.00139
By:
- Ravandi, Farhad
Publication type:
Article
Evolving therapy of adult acute lymphoblastic leukemia: state-of-the-art treatment and future directions.
Published in:
Journal of Hematology & Oncology, 2020, v. 13, n. 1, p. 1, doi. 10.1186/s13045-020-00905-2
By:
- Samra, Bachar;
- Jabbour, Elias;
- Ravandi, Farhad;
- Kantarjian, Hagop;
- Short, Nicholas J.
Publication type:
Article
Tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia: a single-institution experience.
Published in:
Journal of Hematology & Oncology, 2019, v. 12, n. 1, p. N.PAG, doi. 10.1186/s13045-018-0686-1
By:
- Chamoun, Kamal;
- Kantarjian, Hagop;
- Atallah, Rami;
- Gonzalez, Graciela Nogueras;
- Issa, Ghayas C.;
- Rios, Mary Beth;
- Garcia-Manero, Guillermo;
- Borthakur, Gautam;
- Ravandi, Farhad;
- Jain, Nitin;
- Daver, Naval;
- Konopleva, Marina;
- DiNardo, Courtney D.;
- Kadia, Tapan;
- Pemmaraju, Naveen;
- Jabbour, Elias;
- Cortes, Jorge
Publication type:
Article
Incidence of extramedullary disease in patients with acute promyelocytic leukemia: a single-institution experience.
Published in:
2009
By:
- Vega-Ruiz, Arturo;
- Faderl, Stefan;
- Estrov, Zeev;
- Pierce, Sherry;
- Cortes, Jorge;
- Kantarjian, Hagop;
- Ravandi, Farhad
Publication type:
journal article
Current Approaches to Philadelphia Chromosome–Positive B-Cell Lineage Acute Lymphoblastic Leukemia: Role of Tyrosine Kinase Inhibitor and Stem Cell Transplant.
Published in:
Current Oncology Reports, 2021, v. 23, n. 8, p. 1, doi. 10.1007/s11912-021-01086-y
By:
- Kim, Kunhwa;
- Jabbour, Elias;
- Short, Nicholas J.;
- Kebriaei, Partow;
- Kantarjian, Hagop;
- Ravandi, Farhad
Publication type:
Article
T-Cell Prolymphocytic Leukemia: A Single-Institution Experience.
Published in:
Clinical Lymphoma & Myeloma, 2005, v. 6, n. 3, p. 234
By:
- Ravandi, Farhad;
- O'Brien, Susan;
- Jones, Dan;
- Lerner, Susan;
- Faderl, Stefan;
- Ferrajoli, Alessandra;
- Wierda, William;
- Garcia-Manero, Guillermo;
- Thomas, Deborah;
- Koller, Charles;
- Verstovsek, Srdan;
- Giles, Francis;
- Cortes, Jorge;
- Herling, Marco;
- Kantarjian, Hagop;
- Keating, Michael
Publication type:
Article
Clinical Outcomes and Co-Occurring Mutations in Patients with RUNX1-Mutated Acute Myeloid Leukemia.
Published in:
International Journal of Molecular Sciences, 2017, v. 18, n. 8, p. 1618, doi. 10.3390/ijms18081618
By:
- Khan, Maliha;
- Cortes, Jorge;
- Kadia, Tapan;
- Naqvi, Kiran;
- Brandt, Mark;
- Pierce, Sherry;
- Patel, Keyur P.;
- Borthakur, Gautam;
- Ravandi, Farhad;
- Konopleva, Marina;
- Kornblau, Steven;
- Kantarjian, Hagop;
- Bhalla, Kapil;
- DiNardo, Courtney D.
Publication type:
Article
Increased Oxidative Stress in Acute Myeloid Leukemia Patients after Red Blood Cell Transfusion, but Not Platelet Transfusion, Results Mainly from the Oxidative/Nitrative Protein Damage: An Exploratory Study.
Published in:
Journal of Clinical Medicine, 2021, v. 10, n. 7, p. 1349, doi. 10.3390/jcm10071349
By:
- Czubak-Prowizor, Kamila;
- Trelinski, Jacek;
- Stelmach, Paulina;
- Stelmach, Piotr;
- Madon, Agnieszka;
- Zbikowska, Halina Malgorzata;
- Ravandi-Kashani, Farhad
Publication type:
Article
Combination therapy with novel agents for acute myeloid leukaemia: Insights into treatment of a heterogenous disease.
Published in:
British Journal of Haematology, 2024, v. 205, n. 1, p. 30, doi. 10.1111/bjh.19519
By:
- Jen, Wei‐Ying;
- Kantarjian, Hagop;
- Kadia, Tapan M.;
- DiNardo, Courtney D.;
- Issa, Ghayas C.;
- Short, Nicholas J.;
- Yilmaz, Musa;
- Borthakur, Gautam;
- Ravandi, Farhad;
- Daver, Naval G.
Publication type:
Article
Characteristics and outcomes of acute myeloid leukaemia patients with baseline CD7 expression.
Published in:
British Journal of Haematology, 2024, v. 204, n. 6, p. 2259, doi. 10.1111/bjh.19446
By:
- Jen, Wei‐Ying;
- Sasaki, Koji;
- Loghavi, Sanam;
- Wang, Sa A.;
- Qiao, Wei;
- Borthakur, Gautam;
- Ravandi, Farhad;
- Kadia, Tapan M.;
- Issa, Ghayas C.;
- Short, Nicholas J.;
- Yilmaz, Musa;
- Daver, Naval G.;
- DiNardo, Courtney D.
Publication type:
Article
Survival outcomes in patients with acute myeloid leukaemia who received subsequent therapy for relapse in QUAZAR AML‐001.
Published in:
British Journal of Haematology, 2024, v. 204, n. 3, p. 877, doi. 10.1111/bjh.19202
By:
- Ravandi, Farhad;
- Döhner, Hartmut;
- Wei, Andrew H.;
- Montesinos, Pau;
- Pfeilstöcker, Michael;
- Papayannidis, Cristina;
- Lai, Yinzhi;
- Wang, Kefeng;
- See, Wendy L.;
- de Menezes, Daniel Lopes;
- Petrlik, Erica;
- Prebet, Thomas;
- Roboz, Gail J.
Publication type:
Article
Phase 1/2 study of CPX‐351 for patients with Int‐2 or high risk International Prognostic Scoring System myelodysplastic syndromes and chronic myelomonocytic leukaemia after failure to hypomethylating agents.
Published in:
British Journal of Haematology, 2024, v. 204, n. 3, p. 898, doi. 10.1111/bjh.19193
By:
- Montalban‐Bravo, Guillermo;
- Jabbour, Elias;
- Borthakur, Gautam;
- Kadia, Tapan;
- Ravandi, Farhad;
- Chien, Kelly;
- Pemmaraju, Naveen;
- Hammond, Danielle;
- Dong, Xiao Qin;
- Huang, Xuelin;
- Schneider, Heather;
- John, Rosmy;
- Kanagal‐Shamana, Rashmi;
- Loghavi, Sanam;
- Kantarjian, Hagop;
- Garcia‐Manero, Guillermo
Publication type:
Article
Phenotypic subtypes of leukaemic transformation in chronic myelomonocytic leukaemia.
Published in:
British Journal of Haematology, 2023, v. 203, n. 4, p. 581, doi. 10.1111/bjh.19060
By:
- Montalban‐Bravo, Guillermo;
- Kanagal‐Shamanna, Rashmi;
- Li, Ziyi;
- Hammond, Danielle;
- Chien, Kelly;
- Rodriguez‐Sevilla, Juan Jose;
- Sasaki, Koji;
- Jabbour, Elias;
- DiNardo, Courtney;
- Takahashi, Koichi;
- Short, Nicholas;
- Issa, Ghayas C.;
- Pemmaraju, Naveen;
- Kadia, Tapan;
- Ravandi, Farhad;
- Daver, Naval;
- Borthakur, Gautam;
- Loghavi, Sanam;
- Pierce, Sherry;
- Bueso‐Ramos, Carlos
Publication type:
Article
Outcomes of patients with therapy‐related myeloid neoplasms after treatment with poly(ADP‐ribose) polymerase proteins inhibitors for solid tumours.
Published in:
British Journal of Haematology, 2023, v. 201, n. 3, p. e25, doi. 10.1111/bjh.18766
By:
- Almanza‐Huante, Emmanuel;
- Bataller, Alex;
- Urrutia, Samuel;
- Gener‐Ricos, Georgina;
- Briski, Robert Edward;
- Kanagal‐Shamanna, Rashmi;
- Lu, Karen H.;
- Westin, Shannon N.;
- Yap, Timothy A.;
- Takahashi, Koichi;
- Ravandi, Farhad;
- Alvarado, Yesid;
- Kadia, Tapan;
- Sasaki, Koiji;
- Kantarjian, Hagop M.;
- Garcia‐Manero, Guillermo
Publication type:
Article
Flow cytometric immunophenotypic alterations of persistent clonal haematopoiesis in remission bone marrows of patients with NPM1‐mutated acute myeloid leukaemia.
Published in:
British Journal of Haematology, 2021, v. 192, n. 6, p. 1054, doi. 10.1111/bjh.17347
By:
- Loghavi, Sanam;
- DiNardo, Courtney D.;
- Furudate, Ken;
- Takahashi, Koichi;
- Tanaka, Tomoyuki;
- Short, Nicholas J.;
- Kadia, Tapan;
- Konopleva, Marina;
- Kanagal‐Shamanna, Rashmi;
- Farnoud, Noushin R.;
- Pierce, Sherry;
- Khoury, Joseph D.;
- Jorgensen, Jeffrey L.;
- Patel, Keyur P.;
- Daver, Naval;
- Yilmaz, Musa;
- Medeiros, L. Jeffrey;
- Kantarjian, Hagop;
- Ravandi, Farhad;
- Wang, Sa A.
Publication type:
Article
Atypical cases of necrotizing sweet syndrome in patients with myelodysplastic syndrome and acute myeloid leukaemia.
Published in:
British Journal of Haematology, 2020, v. 191, n. 1, p. e10, doi. 10.1111/bjh.16937
By:
- Paul, Shilpa;
- Jammal, Nadya;
- Akhave, Neal;
- Aung, Phyu P.;
- Loghavi, Sanam;
- Jain, Nitin;
- Garcia‐Manero, Guillermo;
- Borthakur, Gautam;
- Verstovsek, Srdan;
- Jabbour, Elias;
- Adachi, Javier;
- Masarova, Lucia;
- Daver, Naval;
- Ravandi, Farhad;
- Pemmaraju, Naveen
Publication type:
Article
Exome analysis of treatment‐related AML after APL suggests secondary evolution.
Published in:
2019
By:
- Wang, Tianjiao;
- Jacoby, Meagan A.;
- Duncavage, Eric J.;
- Miller, Christopher A.;
- Heath, Sharon;
- Rahme, Ramy;
- Fenaux, Pierre;
- Ades, Lionel;
- Renneville, Aline;
- Cassinat, Bruno;
- Takeshita, Akihiro;
- Asou, Norio;
- Miyazaki, Yasushi;
- Kiyoi, Hitoshi;
- Ravandi, Farhad;
- Westervelt, Peter;
- Wartman, Lukas D.;
- Welch, John S.
Publication type:
Case Study
A phase I study of moxetumomab pasudotox in adults with relapsed or refractory B‐cell acute lymphoblastic leukaemia.
Published in:
British Journal of Haematology, 2018, v. 182, n. 3, p. 442, doi. 10.1111/bjh.14806
By:
- Short, Nicholas J.;
- Kantarjian, Hagop;
- Jabbour, Elias;
- Cortes, Jorge E.;
- Thomas, Deborah A.;
- Rytting, Michael E.;
- Daver, Naval;
- Alvarado, Yesid;
- Konopleva, Marina;
- Kebriaei, Partow;
- Wierda, William G.;
- DiNardo, Courtney D.;
- Bivins, Carol;
- McCue, Deborah;
- Richie, Mary A.;
- Ravandi, Farhad
Publication type:
Article
Ocular extramedullary myeloid leukaemia.
Published in:
British Journal of Haematology, 2018, v. 180, n. 5, p. 738, doi. 10.1111/bjh.14430
By:
- Ohanian, Maro;
- Pemmaraju, Naveen;
- Rozovski, Uri;
- Alattar, Mona L.;
- Estrov, Zeev;
- Kundra, Vikas;
- Tung, Cynthia;
- Ravandi, Farhad;
- Manning, John;
- Abruzzo, Lynne V.
Publication type:
Article
How I manage patients with hairy cell leukaemia.
Published in:
British Journal of Haematology, 2017, v. 177, n. 4, p. 543, doi. 10.1111/bjh.14524
By:
- Thompson, Philip A.;
- Ravandi, Farhad
Publication type:
Article
Long-term durable remission by cladribine followed by rituximab in patients with hairy cell leukaemia: update of a phase II trial.
Published in:
British Journal of Haematology, 2016, v. 174, n. 5, p. 760, doi. 10.1111/bjh.14129
By:
- Chihara, Dai;
- Kantarjian, Hagop;
- O'Brien, Susan;
- Jorgensen, Jeffrey;
- Pierce, Sherry;
- Faderl, Stefan;
- Ferrajoli, Alessandra;
- Poku, Rebecca;
- Jain, Preetesh;
- Thompson, Phillip;
- Brandt, Mark;
- Luthra, Rajyalakshmi;
- Burger, Jan;
- Keating, Michael;
- Ravandi, Farhad
Publication type:
Article
Analysis of 2013 European LeukaemiaNet ( ELN) responses in chronic phase CML across four frontline TKI modalities and impact on clinical outcomes.
Published in:
British Journal of Haematology, 2016, v. 173, n. 1, p. 114, doi. 10.1111/bjh.13936
By:
- Jain, Preetesh;
- Kantarjian, Hagop;
- Sasaki, Koji;
- Jabbour, Elias;
- Dasarathula, Jyothsna;
- Nogueras Gonzalez, Graciela;
- Verstovsek, Srdan;
- Borthakur, Gautam;
- Wierda, William;
- Kadia, Tapan;
- Dellasala, Sara;
- Pierce, Sherry;
- Ravandi, Farhad;
- O'Brien, Susan;
- Cortes, Jorge
Publication type:
Article
Minimal residual disease assessed by multi-parameter flow cytometry is highly prognostic in adult patients with acute lymphoblastic leukaemia.
Published in:
British Journal of Haematology, 2016, v. 172, n. 3, p. 392, doi. 10.1111/bjh.13834
By:
- Ravandi, Farhad;
- Jorgensen, Jeffrey L.;
- O'Brien, Susan M.;
- Jabbour, Elias;
- Thomas, Deborah A.;
- Borthakur, Gautam;
- Garris, Rebecca;
- Huang, Xuelin;
- Garcia‐Manero, Guillermo;
- Burger, Jan A.;
- Ferrajoli, Alessandra;
- Wierda, William;
- Kadia, Tapan;
- Jain, Nitin;
- Wang, Sa A.;
- Konoplev, Sergei;
- Kebriaei, Partow;
- Champlin, Richard E.;
- McCue, Deborah;
- Estrov, Zeev
Publication type:
Article
Tamibarotene in patients with acute promyelocytic leukaemia relapsing after treatment with all- trans retinoic acid and arsenic trioxide.
Published in:
British Journal of Haematology, 2015, v. 171, n. 4, p. 471, doi. 10.1111/bjh.13607
By:
- Sanford, David;
- Lo‐Coco, Francesco;
- Sanz, Miguel A.;
- Di Bona, Eros;
- Coutre, Steven;
- Altman, Jessica K.;
- Wetzler, Meir;
- Allen, Steven L.;
- Ravandi, Farhad;
- Kantarjian, Hagop;
- Cortes, Jorge E.
Publication type:
Article
Prognostic significance of the Medical Research Council cytogenetic classification compared with the European LeukaemiaNet risk classification system in acute myeloid leukaemia.
Published in:
British Journal of Haematology, 2015, v. 170, n. 4, p. 590, doi. 10.1111/bjh.13319
By:
- Kadia, Tapan;
- Kantarjian, Hagop;
- Garcia‐Manero, Guillermo;
- Borthakur, Gautam;
- Wang, Xuemei;
- Patel, Keyur;
- Jabbour, Elias;
- Brandt, Mark;
- Daver, Naval;
- Pemmaraju, Naveen;
- Pierce, Sherry;
- Cortes, Jorge;
- Ravandi, Farhad
Publication type:
Article
Very high levels of lactate dehydrogenase at diagnosis predict central nervous system relapse in acute promyelocytic leukaemia.
Published in:
British Journal of Haematology, 2015, v. 169, n. 4, p. 595, doi. 10.1111/bjh.13230
By:
- Ohanian, Maro;
- Rozovski, Uri;
- Ravandi, Farhad;
- Garcia‐Manero, Guillermo;
- Jabbour, Elias;
- Kantarjian, Hagop M.;
- Estrov, Zeev
Publication type:
Article
REVEAL-1, a phase 2 dose regimen optimization study of vosaroxin in older poor-risk patients with previously untreated acute myeloid leukaemia.
Published in:
British Journal of Haematology, 2015, v. 168, n. 6, p. 796, doi. 10.1111/bjh.13214
By:
- Stuart, Robert K.;
- Cripe, Larry D.;
- Maris, Michael B.;
- Cooper, Maureen A.;
- Stone, Richard M.;
- Dakhil, Shaker R.;
- Turturro, Francesco;
- Stock, Wendy;
- Mason, James;
- Shami, Paul J.;
- Strickland, Stephen A.;
- Costa, Luciano J.;
- Borthakur, Gautam;
- Michelson, Glenn C.;
- Fox, Judith A.;
- Leavitt, Richard D.;
- Ravandi, Farhad
Publication type:
Article
Clinical characteristics and outcomes in patients with acute promyelocytic leukaemia and hyperleucocytosis.
Published in:
British Journal of Haematology, 2015, v. 168, n. 5, p. 646, doi. 10.1111/bjh.13189
By:
- Daver, Naval;
- Kantarjian, Hagop;
- Marcucci, Guido;
- Pierce, Sherry;
- Brandt, Mark;
- Dinardo, Courtney;
- Pemmaraju, Naveen;
- Garcia‐Manero, Guillermo;
- O'Brien, Susan;
- Ferrajoli, Alessandra;
- Verstovsek, Srdan;
- Popat, Uday;
- Hosing, Chitra;
- Anderlini, Paolo;
- Borthakur, Gautam;
- Kadia, Tapan;
- Cortes, Jorge;
- Ravandi, Farhad
Publication type:
Article
Safety and clinical activity of 5-aza-2′-deoxycytidine (decitabine) with or without Hyper- CVAD in relapsed/refractory acute lymphocytic leukaemia.
Published in:
British Journal of Haematology, 2014, v. 167, n. 3, p. 356, doi. 10.1111/bjh.13050
By:
- Benton, Christopher B.;
- Thomas, Deborah A.;
- Yang, Hui;
- Ravandi, Farhad;
- Rytting, Michael;
- O'Brien, Susan;
- Franklin, Anna R.;
- Borthakur, Gautam;
- Dara, Samuel;
- Kwari, Monica;
- Pierce, Sherry R.;
- Jabbour, Elias;
- Kantarjian, Hagop;
- Garcia‐Manero, Guillermo
Publication type:
Article
The bruton tyrosine kinase inhibitor ibrutinib ( PCI-32765) blocks hairy cell leukaemia survival, proliferation and B cell receptor signalling: a new therapeutic approach.
Published in:
British Journal of Haematology, 2014, v. 166, n. 2, p. 177, doi. 10.1111/bjh.12867
By:
- Sivina, Mariela;
- Kreitman, Robert J.;
- Arons, Evgeny;
- Ravandi, Farhad;
- Burger, Jan A.
Publication type:
Article
A model for prediction of FLT3- ITD and NPM1 (without FLT3- ITD) positivity in patients with newly diagnosed acute myeloid leukaemia.
Published in:
British Journal of Haematology, 2013, v. 163, n. 1, p. 130, doi. 10.1111/bjh.12450
By:
- Ostronoff, Fabiana;
- Othus, Megan;
- Kantarjian, Hagop M.;
- Meshinchi, Soheil;
- Ravandi, Farhad;
- Hendrie, Paul C.;
- Faderl, Stefan;
- Becker, Pamela S.;
- Cortes, Jorge E.;
- Pagel, John M.;
- Petersdorf, Stephen H.;
- Godwin, John E.;
- Willman, Cheryl L.;
- Pierce, Sherry A.;
- List, Alan F.;
- Sandhu, Ravinder K.;
- Walter, Roland B.;
- Stirewalt, Derek L.;
- Appelbaum, Frederick R.;
- Estey, Elihu H.
Publication type:
Article
Salvage therapy using FLT3 inhibitors may improve long-term outcome of relapsed or refractory AML in patients with FLT3- ITD.
Published in:
British Journal of Haematology, 2013, v. 161, n. 5, p. 659, doi. 10.1111/bjh.12299
By:
- Takahashi, Koichi;
- Kantarjian, Hagop;
- Pemmaraju, Naveen;
- Andreeff, Michael;
- Borthakur, Gautam;
- Faderl, Stefan;
- Garcia‐Manero, Guillermo;
- Pierce, Sherry;
- Luthra, Rajyalakshmi;
- Cardenas‐Turanzas, Marylou;
- Estrov, Zeev;
- Ravandi, Farhad;
- Cortes, Jorge
Publication type:
Article
Optical genome mapping improves the accuracy of classification, risk stratification, and personalized treatment strategies for patients with acute myeloid leukemia.
Published in:
American Journal of Hematology, 2024, v. 99, n. 10, p. 1959, doi. 10.1002/ajh.27435
By:
- Loghavi, Sanam;
- Wei, Qing;
- Ravandi, Farhad;
- Quesada, Andres E.;
- Routbort, Mark J.;
- Hu, Shimin;
- Toruner, Gokce A.;
- Wang, Sa A.;
- Wang, Wei;
- Miranda, Roberto N.;
- Li, Shaoying;
- Xu, Jie;
- DiNardo, Courtney D.;
- Daver, Naval;
- Kadia, Tapan M.;
- Issa, Ghayas C.;
- Kantarjian, Hagop M.;
- Medeiros, L. Jeffrey;
- Tang, Guilin
Publication type:
Article
Exploring the landscape of somatic ASXL2 mutations in myeloid neoplasms: Frequency and clinical implications.
Published in:
American Journal of Hematology, 2024, v. 99, n. 7, p. 1434, doi. 10.1002/ajh.27333
By:
- Abuasab, Tareq;
- Borthakur, Gautam;
- Kanagal‐Shamanna, Rashmi;
- Masarova, Lucia;
- Patel, Keyur;
- Takahashi, Koichi;
- Bose, Prithviraj;
- Villarreal, John;
- Pierce, Sherry;
- Kadia, Tapan;
- Garcia‐Manero, Guillermo;
- Short, Nicholas J.;
- DiNardo, Courtney;
- Daver, Naval;
- Ravandi, Farhad;
- Kantarjian, Hagop;
- Verstovsek, Srdan;
- Yilmaz, Musa
Publication type:
Article
Characteristics and outcomes of patients with relapsed Philadelphia chromosome‐positive acute lymphoblastic leukemia after failure of a frontline ponatinib‐containing therapy.
Published in:
American Journal of Hematology, 2024, v. 99, n. 7, p. 1423, doi. 10.1002/ajh.27329
By:
- Short, Nicholas J.;
- Jabbour, Elias;
- Nasr, Lewis F.;
- Jain, Nitin;
- Haddad, Fadi G.;
- Issa, Ghayas C.;
- Sasaki, Koji;
- Senapati, Jayastu;
- Kebriaei, Partow;
- Garris, Rebecca;
- Konopleva, Marina;
- Ravandi, Farhad;
- Kantarjian, Hagop
Publication type:
Article
Targetable genetic abnormalities in patients with acute myeloblastic leukemia across age groups.
Published in:
American Journal of Hematology, 2024, v. 99, n. 4, p. 792, doi. 10.1002/ajh.27236
By:
- Bataller, Alex;
- DiNardo, Courtney D.;
- Bazinet, Alexandre;
- Daver, Naval G.;
- Maiti, Abhishek;
- Borthakur, Gautam;
- Short, Nicholas;
- Sasaki, Koji;
- Jabbour, Elias J.;
- Issa, Ghayas C.;
- Pemmaraju, Naveen;
- Yilmaz, Musa;
- Montalban‐Bravo, Guillermo;
- Loghavi, Sanam;
- Garcia‐Manero, Guillermo;
- Ravandi, Farhad;
- Kantarjian, Hagop M.;
- Kadia, Tapan M.
Publication type:
Article
Measurable residual disease monitoring in patients with acute myeloid leukemia treated with lower‐intensity therapy: Roadmap from an ELN‐DAVID expert panel.
Published in:
American Journal of Hematology, 2023, v. 98, n. 12, p. 1847, doi. 10.1002/ajh.27087
By:
- Ravandi, Farhad;
- Cloos, Jacqueline;
- Buccisano, Francesco;
- Dillon, Richard;
- Döhner, Konstanze;
- Freeman, Sylvie D.;
- Hourigan, Christopher S.;
- Ossenkoppele, Gerrit J.;
- Roboz, Gail J.;
- Subklewe, Marion;
- Thiede, Christian;
- Arnhardt, Isabell;
- Valk, Peter J. M.;
- Venditti, Adriano;
- Wei, Andrew H.;
- Walter, Roland B.;
- Heuser, Michael
Publication type:
Article
Phase II study of cladribine, idarubicin, and ara‐C (CLIA) with or without sorafenib as initial therapy for patients with acute myeloid leukemia.
Published in:
American Journal of Hematology, 2023, v. 98, n. 11, p. 1711, doi. 10.1002/ajh.27054
By:
- Kadia, Tapan M.;
- Ravandi, Farhad;
- Molica, Matteo;
- Bataller, Alex;
- Borthakur, Gautam;
- Daver, Naval;
- Jabbour, Elias;
- DiNardo, Courtney D.;
- Pemmaraju, Naveen;
- Jain, Nitin;
- Ferrajoli, Alessandra;
- Ylimaz, Musa;
- Bose, Prithviraj;
- Tidwell, Rebecca Slack;
- Marx, Kayleigh R.;
- Rausch, Caitlin R.;
- Kanagal‐Shamanna, Rashmi;
- Wang, Sa;
- Islam, Rabiul;
- Champlin, Richard
Publication type:
Article
Characteristics and clinical outcomes of patients with myeloid malignancies and DDX41 variants.
Published in:
American Journal of Hematology, 2023, v. 98, n. 11, p. 1780, doi. 10.1002/ajh.27070
By:
- Bataller, Alex;
- Loghavi, Sanam;
- Gerstein, Yoheved;
- Bazinet, Alexandre;
- Sasaki, Koji;
- Chien, Kelly S.;
- Hammond, Danielle;
- Montalban‐Bravo, Guillermo;
- Borthakur, Gautam;
- Short, Nicholas;
- Issa, Ghayas C.;
- Kadia, Tapan M.;
- Daver, Naval;
- Tang, Guilin;
- Quesada, Andres;
- Patel, Keyur P.;
- Ravandi, Farhad;
- Fiskus, Warren;
- Mill, Cristopher P.;
- Kantarjian, Hagop M.
Publication type:
Article
Performance of IPSS‐M in patients with myelodysplastic syndrome after hypomethylating agent failure.
Published in:
American Journal of Hematology, 2023, v. 98, n. 10, p. E281, doi. 10.1002/ajh.27043
By:
- Urrutia, Samuel;
- Chien, Kelly S.;
- Li, Ziyi;
- Bataller, Alex;
- Almanza, Emmanuel;
- Sasaki, Koji;
- Montalban‐Bravo, Guillermo;
- Short, Nicholas J.;
- Jabbour, Elias;
- Kadia, Tapan M.;
- Ravandi, Farhad;
- Borthakur, Gautam;
- Alvarado, Yesid;
- Daver, Naval;
- Kanagal‐Shamanna, Rashmi;
- Bueso‐Ramos, Carlos;
- Pierce, Sherry A.;
- Kantarjian, Hagop;
- Garcia‐Manero, Guillermo
Publication type:
Article

Found: 465